CDC Suspends $5 Billion in Grants Amid Review of Public Health Funding

Jan 25, 2026, 2:30 AM

Hover over text to view sources

The Centers for Disease Control and Prevention (CDC) has placed a temporary hold on more than 100 grants totaling over $5 billion that were awarded to states to enhance their public health infrastructure. This decision, communicated to state officials via notices, comes as the federal government undertakes a review of these funds to ensure they align with current administration and agency priorities.

According to CDC officials, the pause is part of a new review process aimed at confirming that funds are used for their intended purposes. "The Public Health Infrastructure Grants were temporarily paused so HHS could implement a new review process," stated HHS spokesperson Andrew Nixon. The grants, which began in late 2022, support a variety of public health initiatives, including mental health scheduling modernization and health surveillance improvements.

The abrupt nature of the announcement has left state and local health departments scrambling to assess the financial implications. Many officials expressed surprise, as they had not received prior notice of the funding hold, which was communicated late on a Friday. Public health experts have described these grants as foundational to the country's health systems, referring to them as "the everyday bread and butter" of public health efforts.

This action is not isolated; it follows a pattern of increased scrutiny on federal health funding under the Trump administration, which has previously canceled grants perceived as misaligned with its agenda. Just days before the grant suspension, the Office of Management and Budget had requested a detailed report on federal funding to states led by Democrats, sparking fears among public health advocates that the administration is targeting specific programs.

The grants affected by the pause are vital for various public health initiatives, including emergency preparedness, disease outbreak response, and community health outreach. In total, the CDC had allocated approximately $14.9 billion to state and local jurisdictions in FY 2023, of which a significant portion was designated for public health infrastructure and COVID-19 response efforts.

States are already feeling the repercussions of the funding freeze. California, for instance, has reported a loss of over $700 million in grants, which are used for COVID-19 response and other public health services. Other states, such as Virginia and North Carolina, have indicated that these funding cuts will lead to layoffs and reduced public health services, further complicating their ability to respond to ongoing health challenges.

In response to these developments, several states have taken legal action to challenge the funding cuts. A federal judge recently issued a preliminary injunction against the Department of Health and Human Services (HHS), ruling that the agency's decision to rescind the grants was unlawful and violated Congress's authority to control public health appropriations. This legal battle highlights the contentious nature of federal health funding and the significant role it plays in supporting public health initiatives across the nation.

As public health officials continue to navigate the uncertainty surrounding federal funding, the ongoing review process by HHS raises critical questions about the future of public health infrastructure in the United States. The pause in funding comes at a time when health departments are grappling with the aftermath of the COVID-19 pandemic and the need for robust public health systems to address emerging health threats.

The CDC's decision to suspend these grants underscores the complexities of health funding in the current political climate and the potential consequences for public health initiatives nationwide. As the situation develops, stakeholders will be watching closely to see how these funding changes will affect the ability of states to respond to public health needs and protect the health of their communities.

New Poll Highlights Florida Voter Support for Childhood Vaccine Requirements

A recent poll reveals overwhelming support among Florida voters for maintaining current childhood vaccine requirements as state officials consider potential changes. Despite ongoing debates around exemptions and mandates, evidence suggests that Floridians prioritize public health safeguards.

Nebraska Regents Overhaul Nebraska Medicine Board Amid Legal Turmoil

The University of Nebraska Board of Regents has restructured the Nebraska Medicine Board of Directors following a lawsuit and a contentious $800 million buyout deal with Clarkson Regional Health Services. The changes aim to ensure the organization's stability and future, but have sparked significant debate among lawmakers.

Nebraska Regents Restructure Medicine Board Amid Controversy

In a significant move, the University of Nebraska Board of Regents has reconstituted the Nebraska Medicine Board following serious concerns and a lawsuit. This restructuring is part of an $800 million deal to acquire full control of Nebraska Medicine from Clarkson Regional Health Services.

Congress Revives Bipartisan Health Care Proposal with Drug Provisions

Congress has reintroduced a bipartisan health care proposal aimed at preventing premium spikes and enhancing drug pricing transparency. The Bipartisan Health Insurance Affordability Act includes provisions to regulate pharmacy benefit managers (PBMs) and ensure that savings from drug rebates are passed on to patients.

WV Senate Health Committee Advances Ivermectin OTC Bill

The West Virginia Senate Health Committee has advanced a bill allowing the over-the-counter sale of ivermectin, a drug typically used for treating parasitic infections. The bill, sponsored by Sen. Patricia Rucker, aims to provide easier access to the medication, though concerns about safety and proper dosage have been raised by some committee members.